mTOR Inhibitor Immunosuppressant [EPC]

mTOR Inhibitor Immunosuppressant [EPC] was reported 63135 times

Drugs of the mTOR Inhibitor Immunosuppressant [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC 98 0.4100
1 PANCREATIC NEUROENDOCRINE TUMOUR 177 0.2761
2 SMOOTH MUSCLE CELL NEOPLASM 103 0.2464
3 POLYOMAVIRUS VIRAEMIA 241 0.2269
4 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 507 0.2162
5 PIK3CA-ACTIVATED MUTATION 71 0.2139
6 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 42 0.1772
7 BLOOD CHROMOGRANIN A INCREASED 75 0.1634
8 NEUROENDOCRINE TUMOUR 227 0.1602
9 HUMAN POLYOMAVIRUS INFECTION 78 0.1469
10 MYCOBACTERIUM HAEMOPHILUM INFECTION 40 0.1399
11 BK VIRUS INFECTION 454 0.1345
12 METASTASES TO SKIN 136 0.1317
13 CHRONIC ALLOGRAFT NEPHROPATHY 102 0.1303
14 VIRAEMIA 168 0.1212
15 HUMAN HERPESVIRUS 8 INFECTION 73 0.1199
16 LUNG TRANSPLANT REJECTION 76 0.1152
17 LYMPHOCELE 76 0.1145
18 METASTASES TO THE MEDIASTINUM 46 0.1117
19 MICROSPORIDIA INFECTION 39 0.1111
20 METASTASES TO CHEST WALL 36 0.1037
21 METASTASES TO PLEURA 106 0.1010
22 PARVOVIRUS B19 INFECTION 89 0.0994
23 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 495 0.0972
24 TRICHODYSPLASIA SPINULOSA 37 0.0971
25 HEART TRANSPLANT REJECTION 100 0.0963
26 LIVER TRANSPLANT REJECTION 170 0.0945
27 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 86 0.0929
28 TRANSPLANT REJECTION 713 0.0889
29 CARBOHYDRATE ANTIGEN 15-3 INCREASED 66 0.0867
30 ALVEOLAR PROTEINOSIS 51 0.0861
31 METASTASES TO PANCREAS 37 0.0835
32 RENAL TUBULAR ATROPHY 72 0.0816
33 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 96 0.0800
34 KIDNEY FIBROSIS 137 0.0789
35 METASTATIC RENAL CELL CARCINOMA 144 0.0786
36 EPSTEIN-BARR VIRAEMIA 86 0.0775
37 METASTASES TO ABDOMINAL CAVITY 38 0.0772
38 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 100 0.0759
39 CRYPTOSPORIDIOSIS INFECTION 39 0.0743
40 MALACOPLAKIA 34 0.0742
41 METASTASES TO LIVER 1302 0.0740
42 CHRONIC GRAFT VERSUS HOST DISEASE 265 0.0733
43 LYMPHANGIOSIS CARCINOMATOSA 76 0.0729
44 CELL MARKER INCREASED 34 0.0710
45 BREAST CANCER METASTATIC 730 0.0679
46 THROMBOTIC MICROANGIOPATHY 657 0.0674
47 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 53 0.0673
48 GRAFT VERSUS HOST DISEASE IN LIVER 48 0.0670
49 GRAFT LOSS 48 0.0662
50 ADENOVIRUS INFECTION 191 0.0658
51 METASTASES TO BONE 1073 0.0653
52 METASTASES TO ADRENALS 60 0.0650
53 COMPLICATIONS OF TRANSPLANTED KIDNEY 147 0.0648
54 CARCINOID TUMOUR 48 0.0645
55 GASTRIC ANTRAL VASCULAR ECTASIA 34 0.0643
56 METASTASES TO LUNG 735 0.0636
57 EPSTEIN-BARR VIRUS INFECTION 396 0.0633
58 HEPATITIS E 100 0.0633
59 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 207 0.0626
60 GRAFT VERSUS HOST DISEASE IN SKIN 136 0.0617
61 KIDNEY TRANSPLANT REJECTION 296 0.0616
62 METASTASES TO SPINE 207 0.0615
63 RENAL TRANSPLANT FAILURE 59 0.0597
64 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 126 0.0592
65 CYTOMEGALOVIRUS INFECTION REACTIVATION 250 0.0565
66 TUMOUR MARKER INCREASED 268 0.0558
67 STOMATITIS 3387 0.0558
68 TRANSPLANT FAILURE 131 0.0534
69 METASTASES TO LYMPH NODES 353 0.0522
70 DELAYED GRAFT FUNCTION 37 0.0520
71 TRANSITIONAL CELL CARCINOMA 66 0.0508
72 PNEUMOCYSTIS JIROVECII INFECTION 60 0.0502
73 HEPATIC LESION 217 0.0501
74 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 70 0.0495
75 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 35 0.0487
76 RENAL TUBULAR INJURY 59 0.0486
77 TUMOUR PAIN 64 0.0486
78 PNEUMONITIS 1307 0.0480
79 METASTASES TO PERITONEUM 120 0.0475
80 ACUTE GRAFT VERSUS HOST DISEASE 217 0.0474
81 MALIGNANT NEOPLASM PROGRESSION 4801 0.0468
82 RENAL CANCER METASTATIC 36 0.0468
83 CONCOMITANT DISEASE PROGRESSION 91 0.0465
84 ONCOLOGIC COMPLICATION 44 0.0455
85 CYTOMEGALOVIRUS VIRAEMIA 200 0.0449
86 JC VIRUS INFECTION 71 0.0444
87 HYPERTRIGLYCERIDAEMIA 258 0.0440
88 INTUSSUSCEPTION 42 0.0440
89 CYTOMEGALOVIRUS COLITIS 99 0.0430
90 APHTHOUS ULCER 333 0.0429
91 TRANSPLANT DYSFUNCTION 76 0.0426
92 CYTOMEGALOVIRUS INFECTION 675 0.0406
93 PNEUMONIA CYTOMEGALOVIRAL 78 0.0401
94 RENAL CELL CARCINOMA 193 0.0394
95 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 109 0.0394
96 TUMOUR NECROSIS 41 0.0388
97 MOUTH ULCERATION 810 0.0384
98 OBLITERATIVE BRONCHIOLITIS 49 0.0373
99 DEVICE RELATED THROMBOSIS 36 0.0365
100 HUMAN HERPESVIRUS 6 INFECTION 69 0.0365
101 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 63 0.0356
102 ORAL PAIN 787 0.0351
103 BILE DUCT STENOSIS 42 0.0350
104 MALIGNANT PLEURAL EFFUSION 59 0.0350
105 VARICELLA ZOSTER VIRUS INFECTION 70 0.0337
106 MUCOSAL INFLAMMATION 883 0.0337
107 HEPATIC NEOPLASM 109 0.0334
108 GRAFT VERSUS HOST DISEASE 240 0.0333
109 BONE LESION 118 0.0327
110 SQUAMOUS CELL CARCINOMA OF SKIN 197 0.0326
111 METASTASIS 232 0.0325
112 NEOPLASM PROGRESSION 1059 0.0304
113 BREAST CANCER RECURRENT 95 0.0300
114 SECOND PRIMARY MALIGNANCY 248 0.0298
115 ENCEPHALITIS VIRAL 36 0.0296
116 APHTHOUS STOMATITIS 68 0.0294
117 LYMPHADENOPATHY MEDIASTINAL 56 0.0292
118 LUNG INFILTRATION 256 0.0290
119 PNEUMONIA PSEUDOMONAL 44 0.0287
120 MEAN CELL HAEMOGLOBIN DECREASED 51 0.0278
121 LUNG CONSOLIDATION 77 0.0275
122 GASTROENTERITIS NOROVIRUS 36 0.0271
123 MOUTH INJURY 41 0.0270
124 HEPATIC MASS 52 0.0270
125 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 43 0.0268
126 HAEMOLYTIC URAEMIC SYNDROME 62 0.0267
127 PYELONEPHRITIS ACUTE 52 0.0265
128 LYMPHOEDEMA 181 0.0261
129 CYTOMEGALOVIRUS TEST POSITIVE 46 0.0258
130 NEPHROPATHY TOXIC 288 0.0256
131 IGA NEPHROPATHY 42 0.0253
132 NOROVIRUS INFECTION 36 0.0249
133 PNEUMOCYSTIS JIROVECII PNEUMONIA 250 0.0249
134 KLEBSIELLA INFECTION 124 0.0245
135 BRONCHOPULMONARY ASPERGILLOSIS 188 0.0242
136 NONINFECTIVE GINGIVITIS 35 0.0242
137 PULMONARY TOXICITY 169 0.0239
138 DRUG LEVEL DECREASED 243 0.0239
139 NOCARDIOSIS 61 0.0238
140 METASTASES TO CENTRAL NERVOUS SYSTEM 306 0.0237
141 CARCINOEMBRYONIC ANTIGEN INCREASED 45 0.0232
142 PAPILLOMA VIRAL INFECTION 38 0.0230
143 ACTINIC KERATOSIS 59 0.0227
144 ENTEROCOCCAL INFECTION 108 0.0223
145 BACTERIAL SEPSIS 72 0.0221
146 ESCHERICHIA SEPSIS 64 0.0221
147 INVASIVE DUCTAL BREAST CARCINOMA 60 0.0221
148 ENTEROBACTER INFECTION 37 0.0220
149 CHOLANGITIS 136 0.0219
150 ORGANISING PNEUMONIA 108 0.0218
151 PROTEINURIA 414 0.0218
152 LINEAR IGA DISEASE 36 0.0216
153 LIVER ABSCESS 70 0.0216
154 CONCOMITANT DISEASE AGGRAVATED 132 0.0214
155 SOFT TISSUE INFECTION 39 0.0213
156 CANCER PAIN 54 0.0211
157 DYSLIPIDAEMIA 107 0.0210
158 CACHEXIA 108 0.0210
159 RECURRENT CANCER 85 0.0208
160 PNEUMONIA KLEBSIELLA 38 0.0207
161 NEOPLASM 236 0.0205
162 RENAL MASS 42 0.0204
163 PLEURAL EFFUSION 1234 0.0203
164 RENAL NEOPLASM 43 0.0202
165 DRUG LEVEL INCREASED 333 0.0201
166 ASCITES 584 0.0198
167 ESCHERICHIA INFECTION 162 0.0197
168 CREPITATIONS 58 0.0195
169 METASTASES TO MENINGES 44 0.0193
170 PSEUDOMONAS INFECTION 164 0.0191
171 CYTOMEGALOVIRUS CHORIORETINITIS 37 0.0190
172 BRAIN ABSCESS 48 0.0189
173 PNEUMATOSIS INTESTINALIS 54 0.0189
174 TONGUE ULCERATION 63 0.0186
175 BILE DUCT OBSTRUCTION 35 0.0184
176 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 176 0.0184
177 BODY TEMPERATURE DECREASED 181 0.0184
178 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 47 0.0177
179 HYPERGLYCAEMIA 644 0.0177
180 EXPOSED BONE IN JAW 38 0.0175
181 INTERSTITIAL LUNG DISEASE 848 0.0175
182 OSTEONECROSIS OF JAW 427 0.0172
183 HYPERLIPIDAEMIA 206 0.0172
184 HYPERCHOLESTEROLAEMIA 166 0.0172
185 HYPOPHOSPHATAEMIA 127 0.0172
186 ONYCHOCLASIS 118 0.0171
187 RENAL TUBULAR NECROSIS 168 0.0171
188 INGROWING NAIL 40 0.0169
189 ASPERGILLUS INFECTION 111 0.0169
190 LIPIDS INCREASED 34 0.0168
191 VENOOCCLUSIVE DISEASE 42 0.0168
192 PNEUMONIA FUNGAL 66 0.0167
193 METASTATIC NEOPLASM 72 0.0167
194 BLOOD CREATININE DECREASED 52 0.0166
195 APLASIA PURE RED CELL 57 0.0166
196 BLOOD PRESSURE SYSTOLIC INCREASED 319 0.0163
197 NAIL DISORDER 143 0.0163
198 BLOOD LACTATE DEHYDROGENASE INCREASED 258 0.0163
199 MULTIPLE ORGAN DYSFUNCTION SYNDROME 461 0.0163
200 BLOOD TRIGLYCERIDES INCREASED 287 0.0162
201 CYSTITIS HAEMORRHAGIC 65 0.0161
202 ODYNOPHAGIA 96 0.0161
203 HYDRONEPHROSIS 118 0.0157
204 ESCHERICHIA URINARY TRACT INFECTION 66 0.0155
205 HYPOGAMMAGLOBULINAEMIA 102 0.0155
206 GLOMERULONEPHRITIS 38 0.0155
207 BLOOD CREATININE ABNORMAL 53 0.0153
208 DRUG LEVEL ABOVE THERAPEUTIC 70 0.0153
209 DISEASE PROGRESSION 1805 0.0152
210 BONE CANCER 65 0.0149
211 ESCHERICHIA BACTERAEMIA 35 0.0149
212 EATING DISORDER 316 0.0148
213 PERICARDIAL EFFUSION 343 0.0148
214 ORTHOPNOEA 47 0.0147
215 LUNG NEOPLASM 63 0.0147
216 BLOOD CREATININE INCREASED 962 0.0147
217 URINARY TRACT INFECTION BACTERIAL 37 0.0146
218 HEPATIC PAIN 62 0.0145
219 DRUG LEVEL BELOW THERAPEUTIC 80 0.0145
220 PROTEIN TOTAL DECREASED 54 0.0143
221 SQUAMOUS CELL CARCINOMA 134 0.0142
222 THERAPY PARTIAL RESPONDER 219 0.0140
223 SCLERODERMA 51 0.0140
224 HERPES SIMPLEX 91 0.0140
225 VENOOCCLUSIVE LIVER DISEASE 69 0.0140
226 PORTAL HYPERTENSION 43 0.0139
227 SKIN TOXICITY 78 0.0138
228 APLASTIC ANAEMIA 72 0.0138
229 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 321 0.0138
230 PNEUMONIA BACTERIAL 124 0.0135
231 ORAL DISORDER 99 0.0135
232 ENTERITIS 86 0.0134
233 BLOOD PHOSPHORUS DECREASED 49 0.0134
234 PULMONARY MASS 199 0.0133
235 NORMOCHROMIC NORMOCYTIC ANAEMIA 40 0.0133
236 RHINOVIRUS INFECTION 51 0.0131
237 RALES 76 0.0131
238 WOUND DEHISCENCE 44 0.0130
239 LYMPHOPENIA 184 0.0130
240 GAMMA-GLUTAMYLTRANSFERASE INCREASED 286 0.0129
241 BLOOD ALBUMIN DECREASED 102 0.0128
242 AZOTAEMIA 51 0.0128
243 ATELECTASIS 123 0.0127
244 NEPHROTIC SYNDROME 86 0.0125
245 LARGE INTESTINAL ULCER 34 0.0125
246 DERMATITIS ACNEIFORM 76 0.0125
247 BLOOD PRESSURE DIASTOLIC DECREASED 90 0.0122
248 RENAL IMPAIRMENT 1015 0.0121
249 PORTAL VEIN THROMBOSIS 39 0.0121
250 DRUG RESISTANCE 310 0.0121
251 GINGIVAL PAIN 96 0.0120
252 NEOPLASM MALIGNANT 805 0.0120
253 BACTERIAL INFECTION 225 0.0120
254 FEEDING DISORDER 244 0.0120
255 BLOOD UREA INCREASED 201 0.0120
256 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 90 0.0120
257 BONE MARROW DISORDER 36 0.0119
258 GINGIVITIS 64 0.0119
259 LUNG DISORDER 578 0.0118
260 GINGIVAL SWELLING 52 0.0118
261 HYPERURICAEMIA 48 0.0117
262 CHEILITIS 63 0.0116
263 LYMPHOCYTE COUNT DECREASED 205 0.0116
264 HYPOALBUMINAEMIA 90 0.0116
265 PNEUMOTHORAX 183 0.0115
266 URINE OUTPUT DECREASED 100 0.0114
267 C-REACTIVE PROTEIN INCREASED 416 0.0114
268 GLOMERULAR FILTRATION RATE DECREASED 140 0.0114
269 HEPATIC FIBROSIS 39 0.0114
270 PYELONEPHRITIS 98 0.0113
271 HYPOPHAGIA 288 0.0113
272 PULMONARY ALVEOLAR HAEMORRHAGE 63 0.0112
273 SPINAL PAIN 131 0.0112
274 HEPATOCELLULAR CARCINOMA 85 0.0112
275 SEPTIC SHOCK 486 0.0112
276 PERFORMANCE STATUS DECREASED 52 0.0111
277 IMMUNE THROMBOCYTOPENIA 51 0.0111
278 ENCEPHALITIS 77 0.0111
279 HYPERVOLAEMIA 55 0.0111
280 AUTOIMMUNE HAEMOLYTIC ANAEMIA 38 0.0111
281 DUODENITIS 34 0.0111
282 BLOOD CHOLESTEROL INCREASED 516 0.0111
283 PATHOLOGICAL FRACTURE 56 0.0110
284 DIASTOLIC DYSFUNCTION 34 0.0110
285 HYPERCALCAEMIA 136 0.0110
286 PNEUMONIA VIRAL 35 0.0110
287 EPISTAXIS 816 0.0109
288 INJECTION SITE HYPERSENSITIVITY 34 0.0109
289 UROSEPSIS 100 0.0108
290 CHAPPED LIPS 47 0.0108
291 THROMBOTIC THROMBOCYTOPENIC PURPURA 38 0.0108
292 CYTOPENIA 132 0.0108
293 DIFFUSE LARGE B-CELL LYMPHOMA 83 0.0108
294 BLOOD CREATINE INCREASED 47 0.0106
295 NECROSIS 59 0.0106
296 FAILURE TO THRIVE 55 0.0106
297 RED CELL DISTRIBUTION WIDTH INCREASED 44 0.0106
298 LEUKOPENIA 526 0.0105
299 ACUTE RESPIRATORY DISTRESS SYNDROME 185 0.0104
300 BLOOD ALKALINE PHOSPHATASE INCREASED 258 0.0104
301 ABDOMINAL HERNIA 47 0.0103
302 LUNG INFECTION 159 0.0102
303 PROTEIN URINE PRESENT 51 0.0102
304 HAEMATOTOXICITY 97 0.0102
305 IMMUNOSUPPRESSION 90 0.0102
306 JAUNDICE CHOLESTATIC 36 0.0102
307 HEPATITIS B 61 0.0101
308 SKIN MASS 67 0.0100
309 GENERALISED OEDEMA 124 0.0100
310 BLOOD PRESSURE DIASTOLIC INCREASED 46 0.0100
311 VENOUS THROMBOSIS 39 0.0099
312 TERMINAL STATE 66 0.0099
313 BLOOD MAGNESIUM DECREASED 85 0.0098
314 COVID-19 PNEUMONIA 116 0.0098
315 GENERAL PHYSICAL HEALTH DETERIORATION 1134 0.0098
316 PARONYCHIA 43 0.0098
317 CARDIOPULMONARY FAILURE 38 0.0097
318 MALNUTRITION 109 0.0097
319 DECREASED APPETITE 2246 0.0097
320 HEPATOMEGALY 93 0.0095
321 GASTROENTERITIS 138 0.0094
322 THROMBOCYTOPENIA 1056 0.0094
323 OEDEMA PERIPHERAL 1141 0.0094
324 ERYSIPELAS 47 0.0093
325 PULMONARY HAEMORRHAGE 73 0.0093
326 RESPIRATORY FAILURE 673 0.0092
327 AMYLASE INCREASED 34 0.0092
328 MOUTH SWELLING 53 0.0092
329 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 35 0.0092
330 SUSPECTED OFF LABEL USE 41 0.0091
331 OESOPHAGEAL CANDIDIASIS 36 0.0090
332 BRAIN NEOPLASM 83 0.0090
333 DECREASED IMMUNE RESPONSIVENESS 88 0.0090
334 GASTROINTESTINAL TOXICITY 43 0.0089
335 DEHYDRATION 1193 0.0089
336 POLYNEUROPATHY 107 0.0089
337 HAEMOGLOBIN DECREASED 917 0.0089
338 TENDERNESS 93 0.0089
339 PULMONARY OEDEMA 399 0.0089
340 NAIL DISCOLOURATION 35 0.0089
341 CANDIDA INFECTION 150 0.0089
342 SHOCK HAEMORRHAGIC 72 0.0088
343 BLOOD CALCIUM DECREASED 99 0.0088
344 ANAEMIA 1675 0.0088
345 ELECTROLYTE IMBALANCE 102 0.0088
346 APHAGIA 42 0.0087
347 MUSCULOSKELETAL CHEST PAIN 135 0.0087
348 OVARIAN CYST 87 0.0087
349 HAEMATOCRIT DECREASED 172 0.0087
350 HYPOXIA 305 0.0087
351 OEDEMA 466 0.0086
352 ORAL HERPES 166 0.0085
353 TRANSAMINASES INCREASED 189 0.0085
354 GLOSSODYNIA 190 0.0085
355 ACUTE RESPIRATORY FAILURE 163 0.0085
356 AORTIC VALVE INCOMPETENCE 36 0.0085
357 MULTI-ORGAN FAILURE 145 0.0084
358 TASTE DISORDER 170 0.0084
359 NEPHROPATHY 78 0.0083
360 BONE MARROW FAILURE 169 0.0083
361 PANCYTOPENIA 463 0.0083
362 THERAPY CHANGE 81 0.0082
363 IMPAIRED HEALING 270 0.0082
364 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 50 0.0082
365 ENTEROCOLITIS 47 0.0081
366 SMALL INTESTINAL OBSTRUCTION 100 0.0081
367 YELLOW SKIN 38 0.0081
368 BACTERAEMIA 96 0.0081
369 PROCTALGIA 52 0.0081
370 LARGE INTESTINE PERFORATION 56 0.0081
371 RENAL CYST 64 0.0081
372 LYMPHADENOPATHY 284 0.0080
373 PLATELET COUNT DECREASED 855 0.0080
374 ANURIA 69 0.0080
375 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 66 0.0080
376 ABDOMINAL ABSCESS 35 0.0079
377 SKIN NECROSIS 41 0.0079
378 PRODUCT USE IN UNAPPROVED INDICATION 1958 0.0079
379 MASS 110 0.0079
380 BOWEL MOVEMENT IRREGULARITY 60 0.0078
381 HERPES VIRUS INFECTION 45 0.0078
382 PYREXIA 2703 0.0078
383 ILEUS 97 0.0078
384 ENDOCARDITIS 40 0.0078
385 OESOPHAGITIS 85 0.0078
386 DEATH 6689 0.0078
387 CLOSTRIDIUM DIFFICILE COLITIS 82 0.0077
388 DIARRHOEA HAEMORRHAGIC 72 0.0077
389 ORAL DISCOMFORT 107 0.0077
390 BLOOD POTASSIUM INCREASED 125 0.0077
391 ULCER 122 0.0077
392 SKIN LESION 210 0.0076
393 BLOOD CALCIUM INCREASED 67 0.0076
394 ACUTE KIDNEY INJURY 1169 0.0076
395 CHOLECYSTITIS 91 0.0076
396 LEFT VENTRICULAR DYSFUNCTION 51 0.0076
397 HYPOCALCAEMIA 144 0.0076
398 DIABETES MELLITUS 579 0.0076
399 FLUID INTAKE REDUCED 38 0.0076
400 RED BLOOD CELL COUNT DECREASED 217 0.0076
401 PATHOGEN RESISTANCE 69 0.0076
402 WEIGHT DECREASED 2108 0.0075
403 HEPATIC ENCEPHALOPATHY 70 0.0075
404 HOSPICE CARE 74 0.0075
405 FLANK PAIN 70 0.0075
406 POLYURIA 61 0.0074
407 BREAST CANCER 694 0.0074
408 BONE PAIN 432 0.0074
409 DRUG INTOLERANCE 712 0.0074
410 HEPATIC FAILURE 222 0.0074
411 COUGH 2060 0.0073
412 HYPOKALAEMIA 338 0.0073
413 BASAL CELL CARCINOMA 114 0.0073
414 HYPOVOLAEMIC SHOCK 35 0.0073
415 BLOOD URIC ACID INCREASED 42 0.0073
416 SEPSIS 808 0.0072
417 DUODENAL ULCER 51 0.0072
418 DIARRHOEA 4641 0.0072
419 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 394 0.0072
420 CLOSTRIDIUM DIFFICILE INFECTION 156 0.0071
421 ACUTE PULMONARY OEDEMA 40 0.0071
422 PIGMENTATION DISORDER 44 0.0071
423 HAEMOLYSIS 55 0.0071
424 DRUG INTERACTION 1129 0.0071
425 OLIGURIA 44 0.0071
426 PARTIAL SEIZURES 37 0.0071
427 NODULE 92 0.0070
428 BLOOD PRESSURE INCREASED 1074 0.0070
429 ASPARTATE AMINOTRANSFERASE INCREASED 373 0.0070
430 HEPATIC ENZYME ABNORMAL 35 0.0070
431 ACNE 532 0.0070
432 TOOTHACHE 127 0.0070
433 GASTRITIS 183 0.0069
434 RENAL DISORDER 324 0.0069
435 FURUNCLE 55 0.0069
436 GASTROENTERITIS VIRAL 125 0.0069
437 RESPIRATORY DISTRESS 190 0.0069
438 NEUTROPENIA 933 0.0069
439 INTESTINAL PERFORATION 77 0.0069
440 BLOOD SODIUM DECREASED 129 0.0068
441 PULMONARY CONGESTION 90 0.0068
442 CHOLESTASIS 131 0.0068
443 PNEUMONIA 2207 0.0068
444 SKIN ULCER 176 0.0068
445 MITRAL VALVE INCOMPETENCE 77 0.0068
446 VIRAL INFECTION 225 0.0068
447 EJECTION FRACTION DECREASED 105 0.0067
448 METABOLIC DISORDER 39 0.0067
449 CHOLECYSTITIS ACUTE 38 0.0067
450 BRONCHIECTASIS 45 0.0067
451 LIPASE INCREASED 51 0.0066
452 GENERAL PHYSICAL CONDITION ABNORMAL 45 0.0066
453 RENAL PAIN 70 0.0066
454 SKIN INFECTION 74 0.0066
455 THERAPY NON-RESPONDER 296 0.0066
456 PLEURISY 39 0.0066
457 BLOOD POTASSIUM DECREASED 197 0.0065
458 EYELID OEDEMA 76 0.0065
459 HEPATIC FUNCTION ABNORMAL 244 0.0065
460 DYSPNOEA EXERTIONAL 246 0.0065
461 SEIZURE 754 0.0065
462 RENAL FAILURE 857 0.0064
463 RHINITIS 52 0.0064
464 PHARYNGITIS 80 0.0064
465 INTESTINAL OBSTRUCTION 243 0.0064
466 MOUTH HAEMORRHAGE 47 0.0064
467 COLITIS 243 0.0064
468 PAPULE 45 0.0064
469 NASAL DRYNESS 40 0.0064
470 DYSGEUSIA 474 0.0064
471 AGEUSIA 159 0.0064
472 FEBRILE NEUTROPENIA 421 0.0063
473 HAEMOPTYSIS 176 0.0063
474 PLATELET COUNT INCREASED 82 0.0063
475 SKIN PLAQUE 53 0.0063
476 BREAST MASS 42 0.0062
477 JAUNDICE 168 0.0062
478 PERIPHERAL SWELLING 958 0.0062
479 TRICUSPID VALVE INCOMPETENCE 49 0.0062
480 CARDIAC FAILURE ACUTE 41 0.0061
481 GASTROINTESTINAL INFECTION 55 0.0061
482 ALANINE AMINOTRANSFERASE INCREASED 376 0.0061
483 BLOOD URINE PRESENT 116 0.0061
484 HYPOMAGNESAEMIA 85 0.0061
485 INFLAMMATION 311 0.0060
486 INFECTION 872 0.0060
487 GASTROINTESTINAL INFLAMMATION 47 0.0060
488 FACIAL PARALYSIS 51 0.0060
489 BODY TEMPERATURE INCREASED 122 0.0060
490 LIVER DISORDER 265 0.0060
491 STAPHYLOCOCCAL INFECTION 197 0.0060
492 TACHYPNOEA 81 0.0060
493 POSTOPERATIVE WOUND INFECTION 40 0.0059
494 GROIN PAIN 52 0.0059
495 MYOPATHY 51 0.0059
496 CARDIOMEGALY 72 0.0058
497 HEPATOTOXICITY 130 0.0058
498 RESPIRATORY TRACT INFECTION 152 0.0058
499 BREAST PAIN 62 0.0058
500 HYPOVOLAEMIA 34 0.0058
501 EMBOLISM 48 0.0058
502 LIVER FUNCTION TEST ABNORMAL 168 0.0058
503 ABDOMINAL PAIN 1343 0.0058
504 NEEDLE ISSUE 168 0.0058
505 RETINAL DETACHMENT 53 0.0058
506 IRON DEFICIENCY ANAEMIA 53 0.0057
507 IMMUNODEFICIENCY 85 0.0057
508 COAGULOPATHY 95 0.0057
509 BRAIN OEDEMA 72 0.0057
510 ORAL CANDIDIASIS 75 0.0057
511 LOW DENSITY LIPOPROTEIN INCREASED 44 0.0057
512 PRODUCTIVE COUGH 269 0.0056
513 HEPATITIS C 68 0.0056
514 GASTRIC ULCER 107 0.0056
515 RASH PUSTULAR 41 0.0056
516 RESPIRATORY SYNCYTIAL VIRUS INFECTION 49 0.0056
517 ABNORMAL FAECES 46 0.0056
518 RENAL FAILURE ACUTE 238 0.0056
519 CORONAVIRUS INFECTION 37 0.0056
520 BLOOD BILIRUBIN INCREASED 151 0.0056
521 APPETITE DISORDER 37 0.0056
522 SPINAL COMPRESSION FRACTURE 46 0.0056
523 HYPERTENSION 1177 0.0056
524 LIVER FUNCTION TEST INCREASED 119 0.0055
525 CELLULITIS 279 0.0055
526 RESPIRATORY RATE INCREASED 49 0.0055
527 ASPHYXIA 45 0.0055
528 HEPATITIS 141 0.0055
529 HYPERBILIRUBINAEMIA 57 0.0055
530 ASTHENIA 2067 0.0055
531 CHOLELITHIASIS 180 0.0055
532 NEUTROPHIL COUNT INCREASED 56 0.0055
533 TOOTH INFECTION 72 0.0055
534 DERMATITIS 114 0.0054
535 NEUROTOXICITY 95 0.0054
536 ECCHYMOSIS 37 0.0054
537 VITAMIN D DECREASED 46 0.0054
538 CARDIAC FAILURE 431 0.0054
539 ADRENAL INSUFFICIENCY 65 0.0054
540 TOXICITY TO VARIOUS AGENTS 903 0.0053
541 DYSURIA 196 0.0053
542 SKIN DISORDER 176 0.0053
543 FATIGUE 4107 0.0053
544 THERAPY CESSATION 270 0.0053
545 MELAENA 115 0.0052
546 STATUS EPILEPTICUS 59 0.0052
547 ANGIOEDEMA 231 0.0052
548 PULMONARY FIBROSIS 100 0.0052
549 CARDIOMYOPATHY 77 0.0052
550 ARTERIOSCLEROSIS 49 0.0052
551 HYPOTHYROIDISM 166 0.0052
552 BLOOD GLUCOSE ABNORMAL 96 0.0052
553 NEUTROPHIL COUNT DECREASED 211 0.0052
554 HYPERTRANSAMINASAEMIA 36 0.0052
555 ENCEPHALOPATHY 127 0.0052
556 BLOOD IRON DECREASED 61 0.0051
557 ATAXIA 61 0.0051
558 URINARY TRACT INFECTION 876 0.0051
559 FAECES DISCOLOURED 111 0.0051
560 DYSPHONIA 299 0.0051
561 BLOOD THYROID STIMULATING HORMONE INCREASED 47 0.0051
562 TOOTH ABSCESS 52 0.0051
563 ACIDOSIS 39 0.0051
564 FUNGAL INFECTION 170 0.0051
565 VOMITING 2397 0.0051
566 DYSPNOEA 2874 0.0051
567 HAEMORRHOIDS 99 0.0051
568 RENAL FAILURE CHRONIC 39 0.0051
569 PULMONARY EMBOLISM 481 0.0051
570 EPILEPSY 154 0.0050
571 WOUND INFECTION 55 0.0050
572 TUBULOINTERSTITIAL NEPHRITIS 94 0.0050
573 INCONTINENCE 53 0.0050
574 MUSCULOSKELETAL PAIN 261 0.0050
575 FACE OEDEMA 84 0.0050
576 LEUKOCYTOSIS 90 0.0050
577 MENTAL STATUS CHANGES 138 0.0050
578 CENTRAL NERVOUS SYSTEM LESION 68 0.0049
579 ACUTE MYELOID LEUKAEMIA 77 0.0049
580 DEVICE RELATED INFECTION 76 0.0049
581 HAEMATURIA 169 0.0049
582 RASH 2151 0.0049
583 PERITONITIS 101 0.0049
584 APHONIA 68 0.0049
585 PAIN IN JAW 138 0.0049
586 HEPATIC ENZYME INCREASED 329 0.0048
587 HAEMOLYTIC ANAEMIA 43 0.0048
588 EAR INFECTION 127 0.0048
589 DYSPHAGIA 452 0.0048
590 FLATULENCE 270 0.0048
591 OROPHARYNGEAL PAIN 440 0.0047
592 DRY MOUTH 385 0.0047
593 HEMIPARESIS 80 0.0047
594 BONE DISORDER 86 0.0047
595 METABOLIC ACIDOSIS 150 0.0047
596 DISSEMINATED INTRAVASCULAR COAGULATION 66 0.0047
597 BLISTER 262 0.0047
598 GENERALISED TONIC-CLONIC SEIZURE 77 0.0046
599 ABDOMINAL DISTENSION 484 0.0046
600 WHITE BLOOD CELL COUNT DECREASED 502 0.0046
601 SWOLLEN TONGUE 144 0.0046
602 ACUTE HEPATIC FAILURE 63 0.0046
603 GASTRIC HAEMORRHAGE 53 0.0046
604 OFF LABEL USE 4008 0.0046
605 ANAL INCONTINENCE 41 0.0046
606 BLOOD COUNT ABNORMAL 69 0.0045
607 LETHARGY 261 0.0045
608 HYPOGLYCAEMIA 220 0.0045
609 SPLENOMEGALY 53 0.0045
610 APPENDICITIS 42 0.0045
611 BLOOD GLUCOSE INCREASED 846 0.0045
612 FOLLICULITIS 47 0.0045
613 UPPER RESPIRATORY TRACT INFECTION 207 0.0045
614 HYPERKALAEMIA 157 0.0045
615 MALAISE 1963 0.0045
616 HEPATOCELLULAR INJURY 63 0.0044
617 SPUTUM DISCOLOURED 42 0.0044
618 HEPATIC CIRRHOSIS 83 0.0044
619 SKIN CANCER 95 0.0044
620 PERIPHERAL COLDNESS 60 0.0044
621 ABDOMINAL PAIN UPPER 899 0.0044
622 HAEMORRHAGIC STROKE 34 0.0043
623 HAEMATEMESIS 110 0.0043
624 EOSINOPHIL COUNT INCREASED 36 0.0043
625 SINUS TACHYCARDIA 61 0.0043
626 MALIGNANT MELANOMA 57 0.0043
627 SUDDEN DEATH 45 0.0042
628 OSTEOMYELITIS 77 0.0042
629 RASH GENERALISED 110 0.0042
630 RESPIRATORY DISORDER 127 0.0042
631 CYSTITIS 135 0.0042
632 SECRETION DISCHARGE 53 0.0042
633 UPPER GASTROINTESTINAL HAEMORRHAGE 71 0.0042
634 FULL BLOOD COUNT DECREASED 85 0.0042
635 MYELODYSPLASTIC SYNDROME 61 0.0042
636 HEMIPLEGIA 35 0.0042
637 ABSCESS 67 0.0042
638 LIP DRY 38 0.0042
639 BLOOD PRESSURE ABNORMAL 83 0.0042
640 PHARYNGITIS STREPTOCOCCAL 45 0.0042
641 HYPERTENSIVE CRISIS 46 0.0041
642 HAEMATOMA 107 0.0041
643 CONSTIPATION 899 0.0041
644 WOUND 115 0.0041
645 END STAGE RENAL DISEASE 75 0.0041
646 GINGIVAL BLEEDING 56 0.0041
647 RHABDOMYOLYSIS 170 0.0041
648 GOUT 73 0.0041
649 NAUSEA 3182 0.0040
650 ASPIRATION 44 0.0040
651 HYPONATRAEMIA 226 0.0040
652 TOOTH DISORDER 89 0.0040
653 CHRONIC KIDNEY DISEASE 304 0.0040
654 FLUID RETENTION 203 0.0040
655 DISEASE RECURRENCE 188 0.0039
656 HERPES ZOSTER 227 0.0039
657 CHILLS 462 0.0039
658 DRY SKIN 524 0.0039
659 BACK PAIN 905 0.0039
660 HEPATIC STEATOSIS 72 0.0039
661 EAR PAIN 75 0.0039
662 LIP SWELLING 128 0.0038
663 FACIAL PAIN 34 0.0038
664 BLOOD PRESSURE DECREASED 253 0.0038
665 REBOUND EFFECT 43 0.0038
666 PULMONARY HYPERTENSION 79 0.0038
667 LOCAL SWELLING 66 0.0038
668 GASTROINTESTINAL HAEMORRHAGE 315 0.0038
669 INFLUENZA 419 0.0038
670 GALLBLADDER DISORDER 67 0.0037
671 RHINORRHOEA 242 0.0037
672 SWELLING FACE 243 0.0037
673 THROMBOSIS 299 0.0037
674 NO THERAPEUTIC RESPONSE 45 0.0037
675 ABNORMAL BEHAVIOUR 146 0.0037
676 THERAPY INTERRUPTED 263 0.0037
677 MOVEMENT DISORDER 118 0.0037
678 TREATMENT FAILURE 304 0.0037
679 KIDNEY INFECTION 72 0.0037
680 PRURITUS GENERALISED 79 0.0036
681 DEEP VEIN THROMBOSIS 235 0.0036
682 FREQUENT BOWEL MOVEMENTS 97 0.0036
683 WHITE BLOOD CELL COUNT INCREASED 137 0.0036
684 ABDOMINAL PAIN LOWER 90 0.0036
685 DIABETES MELLITUS INADEQUATE CONTROL 63 0.0036
686 SWELLING 332 0.0035
687 RENAL CANCER 168 0.0035
688 DENTAL CARIES 39 0.0035
689 SKIN DISCOLOURATION 162 0.0035
690 HERNIA 68 0.0035
691 HYPOKINESIA 51 0.0035
692 COVID-19 615 0.0035
693 CHEST PAIN 649 0.0035
694 BLOOD PRESSURE FLUCTUATION 84 0.0035
695 MYELOSUPPRESSION 126 0.0035
696 IMMUNE SYSTEM DISORDER 46 0.0035
697 FEELING COLD 97 0.0035
698 ABDOMINAL DISCOMFORT 584 0.0035
699 PANCREATITIS ACUTE 78 0.0035
700 FISTULA 39 0.0035
701 PRODUCT USE ISSUE 652 0.0035
702 POLLAKIURIA 144 0.0034
703 NIGHT SWEATS 111 0.0034
704 PNEUMONIA ASPIRATION 86 0.0034
705 LIGAMENT SPRAIN 34 0.0034
706 SHOCK 79 0.0034
707 PANCREATITIS 181 0.0034
708 PALLOR 93 0.0034
709 RASH PRURITIC 185 0.0034
710 HYPOACUSIS 146 0.0034
711 BLOOD GLUCOSE FLUCTUATION 37 0.0034
712 NEUROPATHY PERIPHERAL 320 0.0034
713 MYOCLONUS 40 0.0034
714 HAEMORRHAGE INTRACRANIAL 50 0.0033
715 RETCHING 71 0.0033
716 MYOCARDITIS 38 0.0033
717 CYANOSIS 52 0.0033
718 GASTROINTESTINAL DISORDER 296 0.0033
719 PELVIC PAIN 60 0.0033
720 FLUID OVERLOAD 48 0.0033
721 CONJUNCTIVITIS 61 0.0033
722 DRUG-INDUCED LIVER INJURY 102 0.0032
723 CIRCULATORY COLLAPSE 55 0.0032
724 HEART RATE DECREASED 113 0.0032
725 HEPATIC CANCER 77 0.0032
726 AMENORRHOEA 56 0.0032
727 EYE INFECTION 36 0.0032
728 SPEECH DISORDER 167 0.0032
729 BLOOD GLUCOSE DECREASED 153 0.0032
730 GASTROINTESTINAL PAIN 35 0.0032
731 NASOPHARYNGITIS 584 0.0032
732 OSTEONECROSIS 104 0.0032
733 INJECTION SITE INDURATION 41 0.0032
734 PHOTOSENSITIVITY REACTION 52 0.0031
735 APHASIA 95 0.0031
736 HEART RATE IRREGULAR 71 0.0031
737 RIB FRACTURE 64 0.0031
738 HYPERSOMNIA 89 0.0031
739 OSTEOPENIA 47 0.0031
740 BLOOD TEST ABNORMAL 43 0.0031
741 DYSSTASIA 89 0.0030
742 CEREBRAL HAEMORRHAGE 109 0.0030
743 HYPOTENSION 609 0.0030
744 GLYCOSYLATED HAEMOGLOBIN INCREASED 76 0.0030
745 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 88 0.0030
746 INJECTION SITE MASS 111 0.0030
747 SKIN REACTION 42 0.0030
748 CYST 37 0.0030
749 LOCALISED INFECTION 72 0.0030
750 INTERNAL HAEMORRHAGE 34 0.0030
751 THERAPEUTIC RESPONSE DECREASED 180 0.0030
752 BLOOD CREATINE PHOSPHOKINASE INCREASED 85 0.0029
753 RASH MACULO-PAPULAR 65 0.0029
754 PAIN IN EXTREMITY 860 0.0029
755 THIRST 52 0.0029
756 JOINT INJURY 62 0.0029
757 LIVER INJURY 71 0.0029
758 JOINT SWELLING 349 0.0029
759 ILLNESS 295 0.0029
760 CARDIOGENIC SHOCK 41 0.0029
761 ACUTE MYOCARDIAL INFARCTION 84 0.0028
762 RESPIRATORY ARREST 78 0.0028
763 CONFUSIONAL STATE 457 0.0028
764 ANGINA PECTORIS 81 0.0028
765 PAIN 1735 0.0028
766 CHOKING 55 0.0028
767 ERYTHEMA 577 0.0028
768 EOSINOPHILIA 49 0.0028
769 MUSCULOSKELETAL DISCOMFORT 48 0.0028
770 SINUSITIS 284 0.0028
771 HEART RATE INCREASED 274 0.0028
772 HYPERTHYROIDISM 40 0.0028
773 THYROID DISORDER 42 0.0027
774 NERVOUS SYSTEM DISORDER 85 0.0027
775 OXYGEN SATURATION DECREASED 153 0.0027
776 DISORIENTATION 107 0.0027
777 SKIN EXFOLIATION 227 0.0027
778 CONTUSION 259 0.0027
779 NASAL CONGESTION 158 0.0027
780 EYE SWELLING 100 0.0027
781 FLUSHING 273 0.0027
782 TACHYCARDIA 238 0.0027
783 BRONCHITIS 198 0.0027
784 HAEMATOCHEZIA 147 0.0027
785 DRUG INEFFECTIVE 3509 0.0027
786 DIVERTICULITIS 73 0.0026
787 MYALGIA 447 0.0026
788 CEREBRAL INFARCTION 64 0.0026
789 PRURITUS 1002 0.0026
790 GAIT INABILITY 87 0.0026
791 HAEMORRHAGE 272 0.0026
792 SEASONAL ALLERGY 36 0.0025
793 LABORATORY TEST ABNORMAL 75 0.0025
794 PHARYNGEAL OEDEMA 39 0.0025
795 TYPE 2 DIABETES MELLITUS 85 0.0025
796 HEADACHE 1580 0.0025
797 GAIT DISTURBANCE 481 0.0025
798 MOOD ALTERED 67 0.0025
799 OSTEOPOROSIS 101 0.0025
800 HYPOAESTHESIA ORAL 37 0.0025
801 NERVOUSNESS 128 0.0024
802 PARALYSIS 35 0.0024
803 LOWER RESPIRATORY TRACT INFECTION 111 0.0024
804 PERICARDITIS 41 0.0024
805 ARTHRALGIA 1012 0.0024
806 HOT FLUSH 183 0.0024
807 URINARY INCONTINENCE 71 0.0024
808 URINARY RETENTION 79 0.0024
809 CARDIOVASCULAR DISORDER 60 0.0024
810 DELIRIUM 82 0.0024
811 ATRIAL FIBRILLATION 230 0.0024
812 LUNG NEOPLASM MALIGNANT 97 0.0024
813 LIMB DISCOMFORT 73 0.0024
814 ISCHAEMIC STROKE 42 0.0024
815 MENSTRUATION IRREGULAR 63 0.0023
816 ALOPECIA 460 0.0023
817 CARDIAC FAILURE CONGESTIVE 188 0.0023
818 AGGRESSION 117 0.0023
819 PRODUCT AVAILABILITY ISSUE 53 0.0023
820 PREMATURE DELIVERY 37 0.0023
821 WHEEZING 137 0.0023
822 DYSPEPSIA 227 0.0023
823 ABASIA 57 0.0023
824 SPINAL FRACTURE 46 0.0023
825 DIABETIC KETOACIDOSIS 55 0.0023
826 SLEEP DISORDER 161 0.0023
827 CHEST DISCOMFORT 233 0.0023
828 SNEEZING 51 0.0023
829 FRACTURE 43 0.0023
830 HOSPITALISATION 349 0.0023
831 LYMPHOMA 35 0.0023
832 RECTAL HAEMORRHAGE 97 0.0023
833 POST PROCEDURAL COMPLICATION 43 0.0022
834 CARDIO-RESPIRATORY ARREST 93 0.0022
835 ERUCTATION 43 0.0022
836 NECK PAIN 124 0.0022
837 LACRIMATION INCREASED 67 0.0022
838 CONDITION AGGRAVATED 674 0.0022
839 CHROMATURIA 50 0.0022
840 SYNCOPE 220 0.0022
841 SCIATICA 35 0.0022
842 MUSCULAR WEAKNESS 249 0.0022
843 CARDIAC ARREST 180 0.0022
844 NEPHROLITHIASIS 100 0.0022
845 DRY EYE 108 0.0022
846 UPPER LIMB FRACTURE 43 0.0022
847 DIPLOPIA 56 0.0022
848 DISCOMFORT 131 0.0021
849 ALTERED STATE OF CONSCIOUSNESS 46 0.0021
850 COMA 101 0.0021
851 CORONARY ARTERY DISEASE 64 0.0021
852 ARRHYTHMIA 99 0.0021
853 ELECTROCARDIOGRAM QT PROLONGED 74 0.0021
854 DIZZINESS 1025 0.0021
855 RASH ERYTHEMATOUS 98 0.0020
856 SKIN FISSURES 40 0.0020
857 SCAR 35 0.0020
858 INSOMNIA 543 0.0020
859 DEAFNESS 53 0.0020
860 BURNING SENSATION 142 0.0020
861 BREAST CANCER FEMALE 54 0.0020
862 HIP FRACTURE 65 0.0020
863 PRODUCT PRESCRIBING ISSUE 44 0.0020
864 GASTROOESOPHAGEAL REFLUX DISEASE 162 0.0020
865 LACTIC ACIDOSIS 65 0.0020
866 CATARACT 119 0.0020
867 POOR QUALITY SLEEP 43 0.0020
868 UNRESPONSIVE TO STIMULI 51 0.0020
869 CONVULSION 113 0.0020
870 FEELING ABNORMAL 472 0.0020
871 INFLUENZA LIKE ILLNESS 162 0.0020
872 PHOTOPHOBIA 37 0.0020
873 FALL 650 0.0020
874 EYE DISORDER 64 0.0019
875 HYPERSENSITIVITY 361 0.0019
876 DEPRESSED MOOD 102 0.0019
877 TREMOR 320 0.0019
878 HYPOAESTHESIA 287 0.0019
879 LOSS OF CONSCIOUSNESS 245 0.0019
880 ECZEMA 100 0.0019
881 HEAD INJURY 60 0.0019
882 AGRANULOCYTOSIS 35 0.0019
883 LOWER LIMB FRACTURE 36 0.0019
884 RENAL INJURY 55 0.0018
885 NEURALGIA 45 0.0018
886 CARDIAC DISORDER 173 0.0018
887 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 333 0.0018
888 RASH PAPULAR 41 0.0018
889 PREMATURE BABY 55 0.0018
890 GASTRIC DISORDER 61 0.0018
891 FEMUR FRACTURE 55 0.0018
892 EXPOSURE DURING PREGNANCY 110 0.0018
893 SINUS DISORDER 35 0.0018
894 LIMB INJURY 48 0.0018
895 INTENTIONAL PRODUCT USE ISSUE 154 0.0018
896 INTERNATIONAL NORMALISED RATIO INCREASED 50 0.0018
897 ROAD TRAFFIC ACCIDENT 73 0.0017
898 PARAESTHESIA 273 0.0017
899 MENORRHAGIA 34 0.0017
900 OSTEOARTHRITIS 73 0.0017
901 PRODUCT PRESCRIBING ERROR 41 0.0017
902 ILL-DEFINED DISORDER 104 0.0017
903 MEMORY IMPAIRMENT 233 0.0017
904 PROCEDURAL PAIN 47 0.0017
905 COGNITIVE DISORDER 79 0.0017
906 SOMNOLENCE 339 0.0017
907 URTICARIA 280 0.0017
908 FEELING HOT 102 0.0017
909 IRRITABILITY 100 0.0017
910 DYSARTHRIA 62 0.0016
911 WEIGHT INCREASED 365 0.0016
912 AMNESIA 106 0.0016
913 PSYCHOTIC DISORDER 48 0.0016
914 AGITATION 119 0.0016
915 MUSCLE SPASMS 297 0.0016
916 DEPRESSED LEVEL OF CONSCIOUSNESS 64 0.0016
917 VERTIGO 98 0.0016
918 ADVERSE DRUG REACTION 142 0.0016
919 OCULAR HYPERAEMIA 74 0.0016
920 CEREBROVASCULAR ACCIDENT 262 0.0015
921 BLINDNESS 63 0.0015
922 VISUAL IMPAIRMENT 190 0.0015
923 THROAT IRRITATION 68 0.0015
924 ANXIETY 428 0.0015
925 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 106 0.0015
926 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 106 0.0015
927 CRYING 54 0.0015
928 PALPITATIONS 172 0.0015
929 MIGRAINE 140 0.0015
930 MEDICATION ERROR 81 0.0015
931 BALANCE DISORDER 124 0.0014
932 MOBILITY DECREASED 103 0.0014
933 DEMENTIA 40 0.0014
934 PANCREATIC CARCINOMA 41 0.0014
935 MYOCARDIAL INFARCTION 246 0.0014
936 PRODUCT DOSE OMISSION 92 0.0014
937 DEPRESSION 320 0.0014
938 RASH MACULAR 49 0.0014
939 SKIN IRRITATION 64 0.0014
940 TREATMENT NONCOMPLIANCE 76 0.0014
941 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 35 0.0014
942 HYPERHIDROSIS 173 0.0013
943 PAIN OF SKIN 36 0.0013
944 SURGERY 77 0.0013
945 PLASMA CELL MYELOMA 51 0.0013
946 DYSKINESIA 53 0.0013
947 EMOTIONAL DISORDER 40 0.0013
948 MOOD SWINGS 41 0.0013
949 RESTLESSNESS 44 0.0012
950 PRODUCT DOSE OMISSION ISSUE 353 0.0012
951 VISUAL ACUITY REDUCED 39 0.0012
952 VISION BLURRED 159 0.0012
953 ANGER 39 0.0012
954 MENTAL DISORDER 50 0.0011
955 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 58 0.0011
956 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 223 0.0011
957 FOETAL EXPOSURE DURING PREGNANCY 89 0.0011
958 ARTHRITIS 85 0.0011
959 EYE PAIN 60 0.0011
960 NO ADVERSE EVENT 191 0.0011
961 ANAPHYLACTIC REACTION 58 0.0010
962 ASTHMA 118 0.0010
963 TRANSIENT ISCHAEMIC ATTACK 34 0.0010
964 DISTURBANCE IN ATTENTION 54 0.0010
965 ABORTION SPONTANEOUS 40 0.0010
966 THERAPEUTIC RESPONSE UNEXPECTED 44 0.0010
967 ADVERSE EVENT 90 0.0010
968 ARTHROPATHY 51 0.0009
969 MATERNAL EXPOSURE DURING PREGNANCY 80 0.0009
970 INCORRECT DOSE ADMINISTERED 199 0.0009
971 TINNITUS 40 0.0009
972 BRADYCARDIA 46 0.0009
973 HALLUCINATION 64 0.0008
974 INJECTION SITE PAIN 242 0.0008
975 MUSCULOSKELETAL STIFFNESS 69 0.0008
976 PRODUCT SUBSTITUTION ISSUE 44 0.0008
977 INJURY 53 0.0008
978 PROSTATE CANCER 59 0.0007
979 INJECTION SITE SWELLING 55 0.0007
980 EYE IRRITATION 41 0.0007
981 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 34 0.0007
982 UNEVALUABLE EVENT 49 0.0006
983 SKIN BURNING SENSATION 46 0.0006
984 UNDERDOSE 44 0.0006
985 INFUSION RELATED REACTION 36 0.0005
986 DRUG DOSE OMISSION 87 0.0005
987 OVERDOSE 99 0.0005
988 INTENTIONAL PRODUCT MISUSE 37 0.0004
989 PRODUCT STORAGE ERROR 34 0.0004
990 PSORIASIS 47 0.0004
991 PRODUCT QUALITY ISSUE 47 0.0003
992 INJECTION SITE ERYTHEMA 40 0.0003